Now Enrolling Children Ages 6–17 with Migraine Attacks
We’re enrolling children (ages 6–17) experiencing migraine headaches for a clinical research study.
This study is evaluating an investigational medication as a potential treatment for preventing migraine attacks in children.
Eligibility Criteria
Your child may qualify if they:
-
Are between 6 and 17 years old
-
Have been diagnosed with migraine headaches for at least 6 months
-
Experience 4–14 migraine headache days per month
What Participants Receive
Qualified participants will receive:
-
Care by a team of experienced doctors and nurses
-
Study-related visits, assessments, and investigational medication at no cost
-
Compensation for time and travel
-
No health insurance required
Benefits of Participation
-
Study care at no cost
-
Dedicated medical staff
-
Help advance pediatric migraine treatment
-
Join a local research study
